World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
78
Citations
19872
World Ranking
1773
National Ranking
874

Medicine

D-Index
78
Citations
19872
World Ranking
18136
National Ranking
9042

Clarence J. Peters publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Clarence J. Peters sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 115 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Clarence J. Peters D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Clarence J. Peters sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 78 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Clarence J. Peters is affiliated with The University of Texas Medical Branch at Galveston in the United States. Their research work is primarily situated in the fields of Medicine and Agricultural and Biological Sciences, with a focus on Infectious Diseases, Ecology, Evolution, Behavior and Systematics, Epidemiology, Pediatrics, Perinatology and Child Health, as well as Public Health, Environmental and Occupational Health.

The scientist's main research topics include:

  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors
  • Vector-Borne Animal Diseases
  • Hepatitis B Virus Studies
  • Assisted Reproductive Technology and Twin Pregnancy
  • Reproductive Biology and Fertility
  • Reproductive Health and Technologies

Clarence J. Peters has authored several papers demonstrating a focus on viral infections and vaccine development. Notable publications include:

  • "Pathology and Pathogenesis of Lassa Fever: Novel Immunohistochemical Findings in Fatal Cases and Clinico-pathologic Correlation," 2021, Clinical Infectious Diseases
  • "Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile," 2020, Vaccine X
  • "Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease," 2022, American Journal of Tropical Medicine and Hygiene
  • "Rift Valley fever MP-12 vaccine elicits an early protective immune response in mice," 2022, Vaccine
  • "Assessment of Operant Learning and Memory in Mice Born through Intracytoplasmic Sperm Injection," 2020, bioRxiv (Cold Spring Harbor Laboratory)

Frequently collaborating with other researchers, their common coauthors include:

  • Douglas M. Watts
  • Darci R. Smith (3 publications)
  • John C. Morrill (3 publications)
  • George E. Bettinger (3 publications)
  • Thomas G. Ksiazek (2 publications)

Clarence J. Peters' work is distributed through several publication venues, with contributions recorded in:

  • Clinical Infectious Diseases
  • Vaccine X
  • American Journal of Tropical Medicine and Hygiene
  • Vaccine
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Nipah Virus: A Recently Emergent Deadly Paramyxovirus

    K. B. Chua;W. J. Bellini;P. A. Rota;B. H. Harcourt

  • The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.

    Anthony Sanchez;Sam G. Trappier;Brian W. J. Mahy;Clarence J. Peters

  • Climate and Satellite Indicators to Forecast Rift Valley Fever Epidemics in Kenya

    Kenneth J. Linthicum;Assaf Anyamba;Compton J. Tucker;Patrick W. Kelley

  • Clinical virology of Ebola hemorrhagic fever (EHF): Virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995

    T. G. Ksiazek;P. E. Rollin;A. J. Williams;D. S. Bressler

  • Markedly elevated levels of interferon (IFN)-γ, IFN-α, interleukin (IL)-2, IL-10, and tumor necrosis factor-α associated with fatal Ebola virus infection

    Francois Villinger;Pierre E. Rollin;Sukhdev S. Brar;Nathaniel F. Chikkala

  • Evaluation of Immune Globulin and Recombinant Interferon-α2b for Treatment of Experimental Ebola Virus Infections

    Peter B. Jahrling;Peter B. Jahrling;Peter B. Jahrling;Thomas Geisbert;Thomas Geisbert;J. B. Geisbert;J. B. Geisbert;J. R. Swearengen;J. R. Swearengen

  • An Outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98

    Christopher W. Woods;Adam M. Karpati;Thomas Grein;Noel McCarthy

  • Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection

    Toshiaki Maruyama;Luis L. Rodriguez;Peter B. Jahrling;Anthony Sanchez

  • Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome.

    C. J. Peters;Gary L. Simpson;H. Levy

  • ELISA for the Detection of Antibodies to Ebola Viruses

    Thomas G. Ksiazek;Thomas G. Ksiazek;Cynthia P. West;Pierre E. Rollin;Pierre E. Rollin;Peter B. Jahrling

  • Syndromic Surveillance and Bioterrorism-related Epidemics

    James W. Buehler;Ruth L. Berkelman;David M. Hartley;Clarence J. Peters

  • Biochemical Analysis of the Secreted and Virion Glycoproteins of Ebola Virus

    Anthony Sanchez;Zhi Yong Yang;Ling Xu;Gary J. Nabel

  • Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis.

    James N Mills;Thomas G Ksiazek;C.J. Peters;James E. Childs

  • An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia.

    R. M. Wells;S. Sosa Estani;Z. E. Yadon;D. Enria

  • Guidelines for Working with Rodents Potentially Infected with Hantavirus

    James N. Mills;Terry L. Yates;James E. Childs;Robert R. Parmenter

  • A Novel Immunohistochemical Assay for the Detection of Ebola Virus in Skin: Implications for Diagnosis, Spread, and Surveillance of Ebola Hemorrhagic Fever

    Sherif R. Zaki;Sherif R. Zaki;Sherif R. Zaki;Wun Ju Shieh;Wun Ju Shieh;Wun Ju Shieh;Patricia W. Greer;Patricia W. Greer;Patricia W. Greer;Cynthia S. Goldsmith;Cynthia S. Goldsmith;Cynthia S. Goldsmith

  • Protective Efficacy of a Live Attenuated Vaccine against Argentine Hemorrhagic Fever

    Julio I. Maiztegui;Kelly T. McKee;Julio G. Barrera Oro;Lee H. Harrison

  • Phylogenetic Analysis of theArenaviridae:Patterns of Virus Evolution and Evidence for Cospeciation between Arenaviruses and Their Rodent Hosts☆☆☆

    Michael D Bowen;Clarence J Peters;Stuart T Nichol

  • Using Remotely Sensed Data To Identify Areas at Risk For Hantavirus Pulmonary Syndrome

    Gregory E. Glass;James E. Cheek;Jonathan A. Patz;Timothy M. Shields

  • Detection and Molecular Characterization of Ebola Viruses Causing Disease in Human and Nonhuman Primates

    Anthony Sanchez;Thomas G. Ksiazek;Pierre E. Rollin;Mary E. G. Miranda

  • Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis.

    F J Burt;R Swanepoel;W J Shieh;J F Smith

  • Patterns of association with host and habitat: Antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States

    Mills Jn;Ksiazek Tg;Ellis Ba;Rollin Pe

Frequent Co-Authors

Thomas G. Ksiazek
Thomas G. Ksiazek The University of Texas Medical Branch at Galveston
Pierre E. Rollin
Pierre E. Rollin Centers for Disease Control and Prevention
Stuart T. Nichol
Stuart T. Nichol Centers for Disease Control and Prevention
Ali S. Khan
Ali S. Khan University of Nebraska Medical Center
Sherif R. Zaki
Sherif R. Zaki Centers for Disease Control and Prevention
Anthony Sanchez
Anthony Sanchez University of Perpignan
James E. Childs
James E. Childs Yale University
James N. Mills
James N. Mills Emory University
Shinji Makino
Shinji Makino The University of Texas Medical Branch at Galveston
Christina F. Spiropoulou
Christina F. Spiropoulou Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse healthcare and research careers. Many students consider complementary paths like nursing and specialized practitioner programs to enhance their clinical expertise alongside immunological knowledge.

For those without a nursing background, exploring accelerated BSN programs for non nurses can be a strategic way to quickly enter the nursing profession. These programs are designed to build foundational clinical skills essential for patient care.

If a more direct entry point into nursing is preferred, there are several lpn programs easy to get into that offer practical training and licensure pathways. These programs often serve as stepping stones for further education.

Advancing beyond initial nursing roles, prospective students may explore nurse practitioner options. The easiest NP programs to get into provide flexible routes to becoming licensed practitioners with specialized skills.

For those interested in mental health, top-ranked best PMHNP programs offer strong clinical placements, combining psychiatric expertise with nursing proficiency, an important complement to immunology’s impact on neuroinflammation and psychosomatic conditions.

By integrating these related degrees and career pathways, students and professionals can broaden their impact in healthcare, contributing to both patient care and immunological research.

Best Scientists Citing Clarence J. Peters

Trending Scientists

Recently Published Articles